The Amaryllidaceae species are well-known as a rich source of bioactive compounds in nature. Although
Hymenocallis littoralis has been studied for decades, its polar components were rarely explored. The current phytochemical investigation of Amaryllidaceae alkaloids from
H. littoralis led to the identification of
[...] Read more.
The Amaryllidaceae species are well-known as a rich source of bioactive compounds in nature. Although
Hymenocallis littoralis has been studied for decades, its polar components were rarely explored. The current phytochemical investigation of Amaryllidaceae alkaloids from
H. littoralis led to the identification of three previously undescribed compounds:
O-demethyl-norlycoramine (
1), (−)-2-
epi-pseudolycorine (
2) and (+)-2-
epi-pseudolycorine (
3), together with eight known compounds: 6α-hydroxyhippeastidine (
4), 6β-hydroxyhippeastidine (
5), lycorine (
6), 2-
epi-lycorine (
7), zephyranthine (
8), ungeremine (
9), pancratistatin (
10) and 9-
O-demethyl-7-
O-methyllycorenine (
11). Among the eight previously reported compounds, five were isolated from
H. littoralis for the first time (compounds
4,
5,
7,
8, and
9). Compounds
1,
4,
5,
7,
8, and
11 exhibited weak anti-SARS-CoV-2 activity (EC
50 = 40–77 µM) at non-cytotoxic concentrations. Assessment of cytotoxicity on the Vero-E6 cell line revealed lycorine and pancratistatin as cytotoxic substances with CC
50 values of 1.2 µM and 0.13 µM, respectively. The preliminary structure-activity relationship for the lycorine-type alkaloids in this study was further investigated, and as a result ring C appears to play a crucial role in their anti-SARS-CoV-2 activity.
Full article
